Jeff Davis Email Address

Executive Director of Special Event Facilities at the University of Texas at Arlington

Book and manage lawn care services at the click of a button. Affordable pricing. Quality guarantee. No contracts. Exterior home maintenance services made easy.

Jeff Davis, Molio’s chief executive, brings 23 successful years of experience in sales, marketing, brand-building and general management at Procter & Gamble both in the USA and abroad. Jeff’s P&G journey spans several different product sectors, including consumer-packaged goods, pharmaceuticals and beauty businesses, in five countries in North America and Europe.Jeff brings this deep expertise to the start-up world at Molio Inc., a creative and analytics agency with a proprietary hyper-targeted media buying capability to build brands with a YouTube first approach. After retiring from P&G in 2009, Jeff was the angel investor, board member and eventual CEO of Orabrush Inc., which pioneered Molio’s model and successfully built the Orabrush tongue cleaner brand. According to Google, Orabrush was one of the first companies to commercialize a product on a global level leveraging YouTube advertising only and recognized Orabrush as one of the most iconic TrueView ads alongside billion dollar brands. DenTek Oral Care acquired the Orabrush brand in 2014. The “Molio Method” has been touted as a disruptive new media approach for building brands and has been recognized by AdAge, the Wall Street Journal, the New York Times, USA Today, Mashable, TechCrunch, ABC’s Nightline, MediaPost and Bloomberg TV.At the University of Utah business school, Jeff serves as adjunct professor and is a published academic author. Jeff serves as a board member to: Hale Centre Theatre; Dermaflage; Larada Sciences and the Lassonde Entrepreneur Institute.Specialties: - Digital Advertising & Brand-building, Start-ups, Consumer, Pharmaceutical and Beauty Businesses- General Mgt., Marketing/Branding, Sales, New Bus. Dev.- Developing markets- Licensing & Acquisition and Co-Promotion in Pharma Industry- Turnaround, Integration, Divestitures and Cost Restructuring- Bilingual: English & German